<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1028-9933</journal-id>
<journal-title><![CDATA[Revista Información Científica]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. inf. cient.]]></abbrev-journal-title>
<issn>1028-9933</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas Guantánamo]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1028-99332023000100060</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Correlación entre BI-RADS 4 y resultados histopatológicos en lesiones atípicas de mama]]></article-title>
<article-title xml:lang="en"><![CDATA[Correlation between BI-RADS 4 and histopathological results in atypical breast lesions]]></article-title>
<article-title xml:lang="pt"><![CDATA[Correlação entre BI-RADS 4 e resultados histopatológicos em lesões mamárias atípicas]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jaramillo-Guerrero]]></surname>
<given-names><![CDATA[Patricio Alonso]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Huilcapi-Carrillo]]></surname>
<given-names><![CDATA[María Fernanda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jácome-Pinela]]></surname>
<given-names><![CDATA[Jerry Paúl]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Milá-Barbier]]></surname>
<given-names><![CDATA[Yuleydis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Regional Autónoma de Los Andes  ]]></institution>
<addr-line><![CDATA[ Ambato]]></addr-line>
<country>Ecuador</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Policlínico Universitario &#8220;4 de Abril&#8221;  ]]></institution>
<addr-line><![CDATA[ Guantánamo]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>102</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1028-99332023000100060&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1028-99332023000100060&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1028-99332023000100060&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  Las lesiones atípicas de la glándula mamaria afectan a un total de 20 000 mujeres en el mundo. La categorización BI-RADS 4 se considera indefinida y tiene variación considerable a malignidad hasta con cinco años de seguimiento.  Objetivo:  Establecer la correlación entre los informes BI-RADS 4 y hallazgos histopatológicos en mujeres con diagnóstico de patología atípica de mama que aceden a la consulta de Ginecología y Obstetricia del Hospital Provincial General Docente de Riobamba, Ecuador.  Método:  Se realizó un estudio de tipo analítico correlacional, retrospectivo, no experimental, de corte transversal en el periodo enero-diciembre de 2021, en 78 pacientes de 20 a 70 años. Los datos fueron tomados de las historias clínicas. Para la validez de pruebas se usó pruebas estadísticas tipo Ji cuadrado de correlación con intervalos de confianza del 95 % e índice de error del 5 %.  Resultados:  El principal factor de riesgo observado fue la edad &#8805;40 años (26,92 %), seguido de: deformidad mamaria (20,51 %), y recurrencia de nódulos (15,38 %). En relación a las subcategorías del informe BI-RADS 4, se observó que el tipo C fue la de mayor prevalencia con 39 casos (50 %). Predominó la hiperplasia ductal con el 44,87 % y la fue de un 95,83 % con una especificidad del 70 %. Hubo una significación asintónica de 0,001 entre BI-RADS 4 y resultados histopatológicos.  Conclusiones:  Las lesiones subcategorizadas como BI-RADS 4C tienen mayor probabilidad de malignizar debido a que se asocian principalmente a hiperplasia ductal, siendo esta el principal cáncer mamario en mujeres mayores de 40 años.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Atypical lesions of the mammary gland affect a total of 20,000 women worldwide. The BI-RADS 4 categorization is considered indefinite and has considerable variation to malignancy with up to five years of follow-up.  Objective:  To establish the correlation between BI-RADS 4 reports and histopathological findings in women with a diagnosis of atypical breast pathology who attend the Gynecology and Obstetrics consultation of the Hospital Provincial General Docente de Riobamba, Ecuador.  Method:  A correlational, retrospective, non-experimental, cross-sectional analytical study was carried out in the period January-December 2021, in 78 patients aged 20 to 70 years. The data were taken from the medical records. For the validity of the tests, Chi-square correlation statistical tests were used with 95% confidence intervals and an error rate of 5%.  Results: The main risk factor observed was age &#8805;40 years (26.92%), followed by: breast deformity (20.51%), and recurrence of nodules (15.38%). In relation to the subcategories of the BI-RADS 4 report, it was observed that type C was the most prevalent with 39 cases (50%). Ductal hyperplasia predominated with 44.87% and was 95.83% with a specificity of 70%. There was an asymptomatic significance of 0.001 between BI-RADS 4 and histopathological results.  Conclusions:  Lesions subcategorized as BI-RADS 4C are more likely to become malignant because they are mainly associated with ductal hyperplasia, this being the main breast cancer in women over 40 years of age.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  Lesões atípicas da glândula mamária afetam um total de 20.000 mulheres em todo o mundo. A categorização BI-RADS 4 é considerada indefinida e apresenta variação considerável para malignidade com até cinco anos de acompanhamento.  Objetivo:  Estabelecer a correlação entre os laudos BI-RADS 4 e os achados histopatológicos em mulheres com diagnóstico de patologia mamária atípica que atendem na consulta de Ginecologia e Obstetrícia do Hospital Provincial General Docente de Riobamba, Equador.  Método:  Estudo correlacional, retrospectivo, não experimental, transversal, analítico, foi realizado no período de janeiro a dezembro de 2021, em 78 pacientes com idade entre 20 e 70 anos. Os dados foram retirados dos prontuários médicos. Para a validade dos testes foram utilizados testes estatísticos de correlação qui-quadrado com intervalos de confiança de 95% e taxa de erro de 5%.  Resultados:  O principal fator de risco observado foi idade &#8805;40 anos (26,92%), seguido de: deformidade mamária (20,51%) e recorrência de nódulos (15,38%). Em relação às subcategorias do relatório BI-RADS 4, observou-se que o tipo C foi o mais prevalente com 39 casos (50%). A hiperplasia ductal predominou com 44,87% e foi de 95,83% com especificidade de 70%. Houve significância assintomática de 0,001 entre o BI-RADS 4 e os resultados histopatológicos.  Conclusões:  Lesões subcategorizadas como BI-RADS 4C têm maior probabilidade de se tornarem malignas porque estão associadas principalmente à hiperplasia ductal, sendo este o principal câncer de mama em mulheres com mais de 40 anos.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[BI-RADS 4]]></kwd>
<kwd lng="es"><![CDATA[lesión glandular atípica de la mama]]></kwd>
<kwd lng="es"><![CDATA[ecografía]]></kwd>
<kwd lng="en"><![CDATA[BI-RADS 4]]></kwd>
<kwd lng="en"><![CDATA[atypical glandular lesion of the breast]]></kwd>
<kwd lng="en"><![CDATA[ultrasound]]></kwd>
<kwd lng="pt"><![CDATA[BI-RADS 4]]></kwd>
<kwd lng="pt"><![CDATA[lesão glandular atípica da mama]]></kwd>
<kwd lng="pt"><![CDATA[ultrassom]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grumpelt]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Ignatov]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tchaikovski]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Burger]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Eggemann]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tumor characteristics and therapy of elderly patients with breast cancer]]></article-title>
<source><![CDATA[J Cancer Res Clin Oncol]]></source>
<year>2016</year>
<volume>142</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1109-16</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Danforth]]></surname>
<given-names><![CDATA[DN.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular profile of atypical hyperplasia of the breast]]></article-title>
<source><![CDATA[Breast Cancer Res Treat]]></source>
<year>2018</year>
<volume>167</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>9-29</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kanbayashi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Iwata]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current approach and future perspective for ductal carcinoma in situ of the breast]]></article-title>
<source><![CDATA[Jpn J Clin Oncol]]></source>
<year>2017</year>
<volume>47</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>671-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yeong]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Thike]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
<name>
<surname><![CDATA[Iqbal]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identifying progression predictors of breast ductal carcinoma in situ]]></article-title>
<source><![CDATA[J Clin Pathol]]></source>
<year>2017</year>
<volume>70</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>102-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrio]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
<name>
<surname><![CDATA[Van Zee]]></surname>
<given-names><![CDATA[KJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Controversies in the Treatment of Ductal Carcinoma in Situ]]></article-title>
<source><![CDATA[Annu Rev Med]]></source>
<year>2017</year>
<volume>68</volume>
<page-range>197-211</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wobb]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Manyam]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kundu]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Arthur]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wazer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Vicini]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of Ductal Carcinoma In Situ of the Breast: A Review]]></article-title>
<source><![CDATA[JAMA Oncol]]></source>
<year>2016</year>
<volume>2</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1083-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheifman]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[BIRADS 5a edición. Ecografía]]></article-title>
<source><![CDATA[Rev Arg Mastol]]></source>
<year>2016</year>
<volume>36</volume>
<numero>127</numero>
<issue>127</issue>
<page-range>44-52</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>American College of Radiology</collab>
<source><![CDATA[Breast Imaging Reporting &amp; Data System (BI-RADS(r))]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[ACR]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Masroor]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rasool]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saeed]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Sohail]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[To asses inter- and intra-observer variability for breast density and BIRADS assessment categories in mammographic reporting]]></article-title>
<source><![CDATA[J Pak Med Assoc]]></source>
<year>2016</year>
<volume>66</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>194-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Okello]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kisembo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bugeza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Galukande]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Breast cancer detection using sonography in women with mammographically dense breasts]]></article-title>
<source><![CDATA[BMC Med Imaging]]></source>
<year>2014</year>
<volume>14</volume>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[YY]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Geng]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Jin]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[XM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The differences of phyllodes and acoustic attenuation in breast lesions diagnosed with Breast Imaging-Reporting and Data System for Ultrasonography (BI-RADS-US) category 4C]]></article-title>
<source><![CDATA[Eur J Gyn Oncol]]></source>
<year>2015</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>294-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elverici]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Barca]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Aktas]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ozsoy]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zengin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cavusoglu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Araz]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation]]></article-title>
<source><![CDATA[Diagn Interv Radiol]]></source>
<year>2015</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>189-94</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Co]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kwong]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Shek]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors affecting the under-diagnosis of atypical ductal hyperplasia diagnosed by core needle biopsies - A 10-year retrospective study and review of the literature]]></article-title>
<source><![CDATA[Int J Sur]]></source>
<year>2018</year>
<volume>49</volume>
<page-range>27-31</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faguy]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Breast Sonography and Mammography: Complementarity and Correlation]]></article-title>
<source><![CDATA[Radiol Technol]]></source>
<year>2017</year>
<volume>89</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>45m-64m</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Punglia]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Bifolck]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Golshan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lehman]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Collins]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Polyak]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[TA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)]]></article-title>
<source><![CDATA[JNCI Cancer Spectr]]></source>
<year>2018</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
